Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph M Connors

Showing results (271-280 of 302) with videos related to

Pageof 31
Sort By:
The New England Journal of Medicine|December 12, 2017
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's LymphomaJoseph M Connors, Wojciech Jurczak, David J Straus, et al.
Blood|September 17, 2013
Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphomaAlyssa Bouska, Timothy W McKeithan, Karen E Deffenbacher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2018
Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell LymphomaDaisuke Ennishi, Aixiang Jiang, Merrill Boyle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2014
Active idiotypic vaccination versus control immunotherapy for follicular lymphomaRonald Levy, Kristen N Ganjoo, John P Leonard, et al.
The American Journal of Pathology|June 25, 2004
BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphomaJaveed Iqbal, Warren G Sanger, Douglas E Horsman, et al.
Blood|February 15, 2007
Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survivalAdrian Wiestner, Mahsa Tehrani, Michael Chiorazzi, et al.
Plos Medicine|December 14, 2016
Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution StudyRobert Kridel, Fong Chun Chan, Anja Mottok, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2017
New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded BiopsiesDavid W Scott, Pau Abrisqueta, George W Wright, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisoneNathalie A Johnson, Graham W Slack, Kerry J Savage, et al.
Blood|July 28, 2005
Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival predictionSilvia Bea, Andreas Zettl, George Wright, et al.
Pageof 31

Showing results (271-280 of 302) with videos related to

Sort By:
Pageof 31
The New England Journal of Medicine|December 12, 2017
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's LymphomaJoseph M Connors, Wojciech Jurczak, David J Straus, et al.
Blood|September 17, 2013
Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphomaAlyssa Bouska, Timothy W McKeithan, Karen E Deffenbacher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2018
Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell LymphomaDaisuke Ennishi, Aixiang Jiang, Merrill Boyle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2014
Active idiotypic vaccination versus control immunotherapy for follicular lymphomaRonald Levy, Kristen N Ganjoo, John P Leonard, et al.
The American Journal of Pathology|June 25, 2004
BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphomaJaveed Iqbal, Warren G Sanger, Douglas E Horsman, et al.
Blood|February 15, 2007
Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survivalAdrian Wiestner, Mahsa Tehrani, Michael Chiorazzi, et al.
Plos Medicine|December 14, 2016
Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution StudyRobert Kridel, Fong Chun Chan, Anja Mottok, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2017
New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded BiopsiesDavid W Scott, Pau Abrisqueta, George W Wright, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisoneNathalie A Johnson, Graham W Slack, Kerry J Savage, et al.
Blood|July 28, 2005
Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival predictionSilvia Bea, Andreas Zettl, George Wright, et al.
Pageof 31